SLC35A1 Gene Glycosylation Disorder Type 2F Genetic Test
Genetic testing plays a crucial role in identifying and diagnosing various genetic disorders. One such disorder is SLC35A1 Gene Glycosylation Disorder Type 2F, also known as congenital disorder of glycosylation type 2F (CDG2F). DNA Labs UAE offers a comprehensive genetic test for this disorder.
Test Name: SLC35A1 Gene Glycosylation Disorder Type 2F Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information:
Prior to undergoing the SLC35A1 Gene Glycosylation Disorder Type 2F Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with Glycosylation disorder type 2F. This information will help in better understanding the genetic context and aid in the interpretation of test results.
Test Details:
The SLC35A1 gene encodes a protein called solute carrier family 35 member A1, which plays a crucial role in glycosylation – the addition of sugar molecules to proteins or lipids. Glycosylation is essential for proper protein folding, stability, and function. SLC35A1 Gene Glycosylation Disorder Type 2F is a rare genetic disorder caused by mutations in the SLC35A1 gene, resulting in abnormal protein glycosylation.
NGS (Next-Generation Sequencing) genetic testing is employed to analyze multiple genes simultaneously. In the case of SLC35A1 Gene Glycosylation Disorder Type 2F, NGS genetic testing identifies mutations or variations in the SLC35A1 gene that may be responsible for the disorder. This test aids in the diagnosis of individuals suspected of having glycosylation disorder type 2F by identifying specific genetic mutations.
NGS genetic testing provides valuable information for genetic counseling, prognostic guidance, and potential treatment decisions. However, it is crucial to note that genetic testing should always be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support based on the test results.
At DNA Labs UAE, we are committed to offering accurate and reliable genetic testing services. Our team of experienced professionals ensures the highest standards of quality and confidentiality. If you suspect a Glycosylation Disorder Type 2F, consider our SLC35A1 Gene Glycosylation Disorder Type 2F Genetic Test for accurate diagnosis and personalized guidance.
| Test Name | SLC35A1 Gene Glycosylation disorder type 2F Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SLC35A1 Gene Glycosylation disorder type 2F NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 2F |
| Test Details |
The SLC35A1 gene is responsible for encoding a protein called solute carrier family 35 member A1. This protein is involved in a process called glycosylation, which is the addition of sugar molecules to proteins or lipids. Glycosylation is important for proper protein folding, stability, and function. Glycosylation disorder type 2F, also known as congenital disorder of glycosylation type 2F (CDG2F), is a rare genetic disorder caused by mutations in the SLC35A1 gene. This disorder affects the glycosylation process, leading to abnormal protein glycosylation. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of SLC35A1 gene glycosylation disorder type 2F, NGS genetic testing can identify mutations or variations in the SLC35A1 gene that may be causing the disorder. NGS genetic testing can help diagnose individuals with suspected glycosylation disorder type 2F by identifying specific genetic mutations. This information can be useful for genetic counseling, providing prognostic information, and potentially guiding treatment decisions. It is important to note that genetic testing should always be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support based on the test results. |
